Article Correctness Is Author's Responsibility: Contact lens for childhood myopia coming to the US in 2020

(McDougall Communications) CooperVision announced it has received US Food and Drug Administration (FDA) approval on Nov. 15, 2019 of its innovative MiSight® 1 day contact lens. The cornerstone of a comprehensive myopia management approach to be offered by CooperVision, this daily wear, single use contact lens is the first and only FDA-approved product clinically proven to slow the progression of myopia (nearsightedness or short-sightedness) when initially prescribed for children 8-12 years old.